RNU6-720P

Across TCGA pan-cancer cohorts, RNU6-720P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RNU6-720P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RNU6-720P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-720P expression acts as an unfavorable survival marker, although some lineages such as ACC and THYM show a favorable association.

ACC, CHOL, and UCEC are the cancer types where RNU6-720P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.981	0.810	.002	56	view →
CHOL	OS	Median	II,III,IV	0.270	0.799	.001	41	view →
UCEC	DFS	Tertile	II,III,IV	0.632	0.764	.027	28	view →
THCA	DFS	Median	II,III,IV	0.771	0.956	.003	25	view →
UVM	OS	Tertile	III,IV	0.037	0.809	<.001	24	view →
LUSC	DFS	Tertile	III,IV	0.341	0.660	.005	22	view →
READ	DFS	Tertile	III,IV	0.408	0.819	.002	22	view →
THYM	DFS	Tertile	II,III,IV	1.000	0.794	.015	21	view →
PCPG	OS	Median	All	0.918	1.000	.003	19	view →
KIRC	DFS	Tertile	All	0.905	0.843	.018	16	view →
GBM	OS	Quartile	All	0.648	0.331	.001	15	view →
PAAD	DFS	Quartile	All	0.305	0.534	.005	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RNU6-720P–ACC (OS)

Open the ACC breakdown →